Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-014690
Filing Date
2025-06-11
Accepted
2025-06-11 16:05:11
Documents
1
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3881
  Complete submission text file 0001641172-25-014690.txt   5380
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 13731 NORTHWOOD RD., NW SEATTLE WA 98177
Business Address
Gilbert Mark John (Reporting) CIK: 0001897698 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40652 | Film No.: 251039925